. Author manuscript; available in PMC: 2024 Dec 1.

Published in final edited form as: J Pain. 2023 Jul 13;24(12):2199–2210. doi: 10.1016/j.jpain.2023.07.006

Table 2.

Analytes Assessed In Serum from CP Patients

Analyte	Abbreviation	References
Interleukin 1beta	IL-1β	^{30, 52}
Interleukin 4	IL-4	^{30, 52}
Interleukin 6	IL-6	^{52, 58}
Interleukin 8	IL-8	^{52, 58}
Interleukin 10	IL-10	^{14, 30, 52, 58}
Interferon gamma	IFNγ	⁴⁸
Tumor necrosis factor alpha	TNFα	^{40, 52, 58}
Transforming growth factor beta 1	TGFβ1	^{28, 31, 40, 55, 75}
Transforming growth factor beta 2	TGFβ2	^{18, 20}
Platelet Derived Growth Factor B	PDGF-B	⁵⁶
Neurotrophin 3	NT-3	⁶⁰
Nerve growth factor	NGF	^{19, 28}
Brain derived neurotrophic factor	BDNF	⁷⁸
Monocyte chemoattractant protein 1	MCP1 (CCL2)	^{28, 52}
Fractalkine	Fractalkine (CX3CL1)	^{12, 13, 31}
Resistin	Resistin	²⁸
Glycoprotein 130	GP130	^{[3, 16, 35]}^* ³⁸
Calcitonin gene related peptide	CGRP	^{8, 52}
Substance P	SP	⁸

references refer to preclinical studies